United States · Federal contract register · Never sold to government
Drugs and biologicals. Names every department and buying office behind the figures, who holds each contract now, its value, contract number and end date, the open notices with their closing dates, and the notices behind every figure.
Assay record ASY-US-0D9TFLR0L7 · Cite as: Assay Systems, “Drugs and biologicals: United States public buying for suppliers with no government contract”, https://assay-systems.com/register/us/never/drugs-and-biologicals/
If your company has never held a contract in the USAspending register, this is what the register records for the line drugs and biologicals as a whole since January 2024. No company is named here; the suppliers who hold the line are listed on its own page.
Since January 2024 the line carries 158,923 contracts with $28,207,463,721 obligated from 12 agencies.
514 suppliers share it.
1,882 contracts since 2024, with $393,644,990 obligated, went to the only supplier that applied.
1,494 more, with $630,079,768 obligated, were awarded directly, with no competition at all.
227 contracts in the line, with $707,335,355 obligated, reach their end dates by September 2027.
139 of them, with $71,368,147 obligated, end in the same month, September 2026.
Names every department and buying office behind the figures, who holds each contract now, its value, contract number and end date, the open notices with their closing dates, and the notices behind every figure.
Source: USAspending.gov, U.S. Department of the Treasury, Bureau of the Fiscal Service, usaspending.gov, accessed 30 September 2026.The data is available to copy, adapt, redistribute, or otherwise use for non-commercial or for commercial purposes (USAspending.gov, Licensing); no Dun & Bradstreet data is shown.